Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengting Ou

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Cancer Drug Targets|May 2, 2018
PRDM14: A Potential Target for Cancer TherapyMengting Ou, Shun Li, Liling Tang
Applied Microbiology and Biotechnology|August 26, 2016
Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapyShun Li, Mengting Ou, Guixue Wang, et al.
Applied Microbiology and Biotechnology|February 5, 2017
A novel inducible lentiviral system for multi-gene expression with human HSP70 promoter and tetracycline-induced promoterShun Li, Lunkun Ma, Mengting Ou, et al.
Oncotarget|December 31, 2016
Estradiol shows anti-skin cancer activities through decreasing MDM2 expressionLi Li, Jianguo Feng, Ying Chen, et al.
Cell Adhesion & Migration|November 5, 2019
Splicing factor-modulated generation of mechano growth factor regulates physiological processes in osteoblasts under mechanical stimuliQian Yi, Huan Liu, Jianguo Feng, et al.
The International Journal of Biochemistry & Cell Biology|July 19, 2017
Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathwayLing He, Ying Chen, Jianguo Feng, et al.
Oncology Reports|May 6, 2021
MDM2 induces EMT via the B‑Raf signaling pathway through 14‑3‑3Mengting Ou, Xichao Xu, Ying Chen, et al.
Molecular Cancer Therapeutics|January 17, 2019
The Rolipram-Perillyl Alcohol Conjugate (NEO214) Is A Mediator of Cell Death through the Death Receptor PathwayHee-Yeon Cho, Thu Zan Thein, Weijun Wang, et al.
Autophagy|August 7, 2023
Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugateMengting Ou, Hee-Yeon Cho, Jie Fu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Cancer Drug Targets|May 2, 2018
PRDM14: A Potential Target for Cancer TherapyMengting Ou, Shun Li, Liling Tang
Applied Microbiology and Biotechnology|August 26, 2016
Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapyShun Li, Mengting Ou, Guixue Wang, et al.
Applied Microbiology and Biotechnology|February 5, 2017
A novel inducible lentiviral system for multi-gene expression with human HSP70 promoter and tetracycline-induced promoterShun Li, Lunkun Ma, Mengting Ou, et al.
Oncotarget|December 31, 2016
Estradiol shows anti-skin cancer activities through decreasing MDM2 expressionLi Li, Jianguo Feng, Ying Chen, et al.
Cell Adhesion & Migration|November 5, 2019
Splicing factor-modulated generation of mechano growth factor regulates physiological processes in osteoblasts under mechanical stimuliQian Yi, Huan Liu, Jianguo Feng, et al.
The International Journal of Biochemistry & Cell Biology|July 19, 2017
Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathwayLing He, Ying Chen, Jianguo Feng, et al.
Oncology Reports|May 6, 2021
MDM2 induces EMT via the B‑Raf signaling pathway through 14‑3‑3Mengting Ou, Xichao Xu, Ying Chen, et al.
Molecular Cancer Therapeutics|January 17, 2019
The Rolipram-Perillyl Alcohol Conjugate (NEO214) Is A Mediator of Cell Death through the Death Receptor PathwayHee-Yeon Cho, Thu Zan Thein, Weijun Wang, et al.
Autophagy|August 7, 2023
Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugateMengting Ou, Hee-Yeon Cho, Jie Fu, et al.
Pageof 1